期刊文献+

常见革兰阴性杆菌对5种β-内酰胺类耐药率比较 被引量:4

Comparison of Drug Resistant Rates of Fiveβ-lactams Against Four Commom Gram-negative Bacilli
下载PDF
导出
摘要 目的:比较常见4种革兰阴性杆菌对5种β-内酰胺类抗生素的耐药率,为临床合理用药提供参考。方法:用纸片扩散法对临床分析的革兰阴性杆菌进行药敏检测,比较其对5种β-内酰胺类抗生素的耐药率。结果:总体耐药率由低到高依次为美洛培南(8.74%)<哌拉西林/他唑巴坦(26.17%)<头孢吡肟(39.60%)<头孢他啶(39.60%)<氨曲南(43.75%)。不同的菌株对不同的抗生素各自的耐药率与总体耐药率存在一定差异。2007年与2006年药敏结果比较,总体抗菌药物耐药率显著上升(P<0.01)。结论:上述5种β-内酰胺类抗生素对革兰阴性菌具有较好的抗菌作用,但应根据菌种的不同合理选用,以减少细菌耐药性的产生。 Objective : To compare the drug resistant rate of five β-lactams against four common gram-negative bacilli to provide reference for clinical usage. Method: An antimicorbial susceptibility testing was done on gram-negative bacilli isolated with Kirby-Bauer method. A comparison of five kinds of β-lactams antibacterial drug resistant rates was made. Result: Meropenem was the lowest drug resistant rate among the five β-lactams antibiotics, which was followed by pip- eracillin-tazobactam. The total drug resistance rates from low to high in order were meropenem ( 8.74% ), piperacillin/ tazobactam ( 26.17 % ), cefepime ( 37.89 % ), ceftazidim ( 39.60% ), and aztreonam ( 43.75 % ). The total resistant rates varied from their respective resistance rate. The total resistant rates increased significantly (P 〈 0.01 ) from 2006 to 2007. Conclusion: All the five β-lactams have positive actions against gram-negative bacilli, but should be selected according to the kind of bacilli to reduce the drug resistance.
出处 《药物流行病学杂志》 CAS 2009年第5期335-338,共4页 Chinese Journal of Pharmacoepidemiology
关键词 Β-内酰胺类抗生素 革兰阴性杆菌 耐药率 β-lactams Bram-negative bacilli Drug resistant rates
  • 相关文献

参考文献12

二级参考文献64

共引文献126

同被引文献32

  • 1刘亚平.我院妇产科医院感染的调查分析[J].护理管理杂志,2005,5(7):10-12. 被引量:12
  • 2朱德妹,汪复,张婴元.2004年上海地区细菌耐药性监测[J].中国抗感染化疗杂志,2005,5(4):195-200. 被引量:227
  • 3曹永红,侯德凤,陆泰远.大肠埃希菌耐药性与抗菌药物使用关联性分析[J].药物流行病学杂志,2007,16(1):30-32. 被引量:9
  • 4朱斌,吴安华,张平,张光文.铜绿假单胞菌质粒介导的AmpCβ-内酰胺酶耐药性的分子生物学研究[J].中华医院感染学杂志,2007,17(8):905-909. 被引量:6
  • 5陈新谦,金有豫,汤光.新编药物学[M].第17版.北京:人民卫生出版社,2011.81.
  • 6金有豫.药理学[M].北京:人民卫生出版社,2002.259-263.
  • 7Yan J J, Hsueh P R, Lu J J, et al. Characterization ofacquired [3-1actamases and their genetic support in multidrug-resistant Pseudomonas aeruginosa isolates in Taiwan: the prevalence of umLsual integrons[J]. JAntimicrob Chemother, 2006, 58(3): 530-536.
  • 8Zhao W H, Hu Z Q. Beta-lactamases identified in clinical isolates of Pseudomonas aentginosa [J]. Crit Rev Microbiol, 2010, 36 (3): 245-258.
  • 9Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing ; Twentieth informational supplement. CLSI/NCCLS document M100-S20. Pennsylvania: Clinical and Laboratory Standards Institute, 2010, 20-143.
  • 10Coudron P E, Moland E S, Thomson K S. Occurrence and detection of AmpC 13-1actamases among Escherichia coli, Klebsiella pneumoniae, and proteus mirabilis at a veterans medical center[J]. J Clin Microbiol, 2000, 38: 1791-1796.

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部